Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 5,003 |
|
|||||
| News | - | ||||||
| Day High | 2.71 | Low High |
|||||
| Day Low | 2.68 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Eupraxia Pharmaceuticals Inc | EPRX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.06 | -2.19% | 2.68 | 15:59:58 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.68 | 2.68 | 2.71 | 2.68 | 2.74 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 33 | 5,003 | US$ 2.68 | US$ 13,408 | - | 2.48 - 3.55 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 6 | US$ 2.72 | USD |
Eupraxia Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 100.67M | 27.28M | - | 0 | -28.22M | -1.03 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Eupraxia Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/11/2024 | 06:00 | PR Newswire (Canada) | Eupraxia Pharmaceuticals Announces Upcoming Presentations at.. |
| 4/08/2024 | 06:00 | PR Newswire (Canada) | Eupraxia Pharmaceuticals To Present at Bloom Burton & Co... |
| 4/05/2024 | 06:00 | PR Newswire (Canada) | Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EPRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.91 | 2.9454 | 2.65 | 2.81 | 15,807 | -0.23 | -7.90% |
| 1 Month | 3.55 | 3.55 | 2.48 | 2.84 | 30,668 | -0.87 | -24.51% |
| 3 Months | 3.55 | 3.55 | 2.48 | 2.84 | 30,668 | -0.87 | -24.51% |
| 6 Months | 3.55 | 3.55 | 2.48 | 2.84 | 30,668 | -0.87 | -24.51% |
| 1 Year | 3.55 | 3.55 | 2.48 | 2.84 | 30,668 | -0.87 | -24.51% |
| 3 Years | 3.55 | 3.55 | 2.48 | 2.84 | 30,668 | -0.87 | -24.51% |
| 5 Years | 3.55 | 3.55 | 2.48 | 2.84 | 30,668 | -0.87 | -24.51% |
Eupraxia Pharmaceuticals Description
| Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations. |
